Literature DB >> 33657212

Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study.

Damon E Houghton1,2,3, Aneel Ashrani2, David Liedl3, Ramila A Mehta4, David O Hodge5, Thom Rooke1,3, Paul Wennberg1,3, Waldemar Wysokinski1,3, Robert McBane1,3.   

Abstract

The calf muscle pump is a major determinate of venous return in the legs but has not been studied as a risk factor for venous thromboembolism (VTE). A population-based cohort study of Olmsted County, Minnesota residents was performed using calf pump function (CPF) measurements from venous plethysmography studies from 1998 to 2015. Patients with a history of VTE were excluded. Nursing validated VTE outcomes from the Rochester Epidemiology Project were identified after the index study date, and patients with reduced CPF (rCPF) were compared with patients with normal CPF. A total of 1532 patients with recorded CPF (28% air and 72% strain gauge plethysmography) were included; 591 (38.5%) had normal CPF, 353 (23.0%) had unilateral rCPF, and 588 (38.3%) had bilateral rCPF. Any VTE occurred in 87 patients (5.7%) after a median follow-up of 11.7 years (range, 0-22.0 years). Comparing patients with bilateral reduced to bilateral normal CPF, the unadjusted hazard ratio (HR) for incident VTE was 2.0 (95% confidence interval [CI], 1.2-3.4) and after adjusting for age, BMI, and Charlson Comorbidity Index, the HR was 1.68 (95% CI, 0.98-2.89). The adjusted HR for ipsilateral deep vein thrombosis was evaluated in 3064 legs comparing legs with reduced to normal CPF and was 1.71 (95% CI, 1.03-2.84). Mortality was significantly higher in both the bilateral (P < .001) and unilateral (P < .001) rCPF groups compared with normal CPF. Our results demonstrate that CPF is a risk factor for VTE in an otherwise low-risk ambulatory population and might be a useful component in risk stratification models.
© 2021 by The American Society of Hematology.

Entities:  

Keywords:  COAGULATION/Thrombotic Disorders and Therapies; calf pump function; deep vein thrombosis; venous thromboembolism; venous thrombosis

Mesh:

Year:  2021        PMID: 33657212      PMCID: PMC8351902          DOI: 10.1182/blood.2020010231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  27 in total

1.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

2.  Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.

Authors:  Alok A Khorana; Mehul Dalal; Jay Lin; Gregory C Connolly
Journal:  Cancer       Date:  2012-08-14       Impact factor: 6.860

3.  Lower extremity venous anatomy.

Authors:  Mark H Meissner
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

4.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

5.  The relation of venous ulceration with ambulatory venous pressure measurements.

Authors:  A N Nicolaides; M K Hussein; G Szendro; D Christopoulos; S Vasdekis; H Clarke
Journal:  J Vasc Surg       Date:  1993-02       Impact factor: 4.268

6.  Calf muscle pump function as a predictor of all-cause mortality.

Authors:  Meghana Halkar; Jose Medina Inojosa; David Liedl; Waldemar Wysokinski; Damon E Houghton; Paul W Wennberg; Grace Lin; Garvan Kane; Karen Fischer; Thom W Rooke; Rayya Saadiq; Amanda Bonikowske; Robert D McBane
Journal:  Vasc Med       Date:  2020-09-25       Impact factor: 3.239

7.  Obesity and impaired venous function.

Authors:  A M van Rij; C S De Alwis; P Jiang; R A Christie; G B Hill; S J Dutton; I A Thomson
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-03-03       Impact factor: 7.069

8.  Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes.

Authors:  Tanya M Petterson; Carin Y Smith; Jane A Emerson; Kent R Bailey; Aneel A Ashrani; John A Heit; Cynthia L Leibson
Journal:  Thromb Haemost       Date:  2018-07-02       Impact factor: 5.249

Review 9.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 10.  Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods.

Authors:  Elham Shabani Varaki; Gaetano D Gargiulo; Stefania Penkala; Paul P Breen
Journal:  Biomed Eng Online       Date:  2018-05-11       Impact factor: 2.819

View more
  2 in total

1.  Which Frequency of Ankle Pump Exercise Should Be Chosen for the Prophylaxis of Deep Vein Thrombosis?

Authors:  Haiyan Li; Wei Zhang; Qingsheng Lu; Jinping Wang; Yanru Zhi; Lingjuan Zhang; Lanshu Zhou
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

2.  Calf muscle pump dysfunction and VTE risk.

Authors:  Andrea T Obi; Thomas W Wakefield
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.